Fortitude Family Office’s AstraZeneca AZN Stock Holding History

Fortitude Family Office’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14K	Hold	6	–	–	﹤0.01%	1703
2026 Q1	$1.18K	Sell	6 -1	-14%	-$193	﹤0.01%	1463
2025 Q4	$1.23K	Hold	7	–	–	﹤0.01%	1376
2025 Q3	$1.03K	Hold	7	–	–	﹤0.01%	1538
2025 Q2	$929	Buy	7 +2	+40%	+$280	﹤0.01%	1549
2025 Q1	$757	Hold	5	–	–	﹤0.01%	1047
2024 Q4	$665	Sell	5 -10	-67%	-$1.4K	﹤0.01%	1192
2024 Q3	$2.35K	Buy	15 +10	+200%	+$1.61K	﹤0.01%	968
2024 Q2	$787	Hold	5	–	–	﹤0.01%	897
2024 Q1	$684	Buy	+5	New	+$662	﹤0.01%	920

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fortitude Family Office's AZN Position: Q2 2026 in Review

Fortitude Family Office held its AstraZeneca (AZN) position steady in Q2 2026 at 6 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Fortitude Family Office first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.35K in Q3 2024. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Fortitude Family Office held 6 shares of AstraZeneca worth $1.14K as of Q2 2026.
Fortitude Family Office left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1703 holding.
Fortitude Family Office first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
Fortitude Family Office's AstraZeneca position peaked at $2.35K in Q3 2024.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.